The Union Cycliste Internationale (UCI) has announced that it has notified Italian rider Fabio Taborre of an Adverse Analytical Finding of FG-4592 (*) in a sample collected during an out-of-competition test on 16 June 2015.FG-4592 is a prohibited substance that has the property of stimulating the endogenous production of EPO.

The rider has the right to request and attend the analysis of the B sample. In accordance with UCI Anti-doping Rules (UCI ADR), the rider has been provisionally suspended until the adjudication of the affair.

This constitutes the second adverse analytical finding for a member of the UCI Professional Continental Team Androni Giocattoli-Sidermec since the beginning of 2015 and within a twelve-month period. On 30 June 2015, the UCI Professional Continental Team Androni Giocattoli-Sidermec Italian rider Davide Appollonio was notified of an adverse analytical finding of EPO in a sample collected during an out-of-competition test on 14 June 2015. Therefore article 7.12.1 in the UCI regulations providing for the suspension of the Team from 15 to 45 days will be applied.

The UCI will refer the matter to the Disciplinary Commission which will render a decision in the upcoming days. At this stage of the procedure, the UCI will not comment any further on any of these matters.